Gilead Sciences Inc. et al. v. Canada (Minister of Health), 2016 FC 231
Linked as:
Extract
Gilead Sciences Inc. et al. v. Canada (Minister of Health), 2016 FC 231
No longer available (Autolink)
See the full content of this document
This document cites
- ViiV Healthcare ULC et al. v. Teva Canada Ltd. et al., (2015) 474 N.R. 235 (FCA)
- Takeda Canada Inc. v. Canada (Minister of Health) et al., (2013) 440 N.R. 346 (FCA)
- Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
- Gilead Sciences Canada Inc. v. Canada (Minister of Health) et al., (2012) 435 N.R. 188 (FCA)
- Purdue Pharma v. Canada (Attorney General) et al., (2011) 417 N.R. 223 (FCA)
